Advisor Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$991K Sell
1,677
-77
-4% -$45.5K 0.07% 292
2022
Q1
$1.23M Buy
1,754
+176
+11% +$123K 0.08% 251
2021
Q4
$997K Buy
1,578
+26
+2% +$16.4K 0.06% 304
2021
Q3
$939K Buy
1,552
+31
+2% +$18.8K 0.06% 291
2021
Q2
$850K Sell
1,521
-59
-4% -$33K 0.06% 332
2021
Q1
$748K Sell
1,580
-126
-7% -$59.7K 0.05% 362
2020
Q4
$824K Sell
1,706
-470
-22% -$227K 0.06% 302
2020
Q3
$1.22M Sell
2,176
-254
-10% -$142K 0.1% 174
2020
Q2
$1.52M Buy
2,430
+631
+35% +$393K 0.14% 145
2020
Q1
$878K Buy
1,799
+933
+108% +$455K 0.11% 182
2019
Q4
$338K Buy
866
+42
+5% +$16.4K 0.03% 455
2019
Q3
$229K Buy
824
+65
+9% +$18.1K 0.03% 576
2019
Q2
$238K Sell
759
-430
-36% -$135K 0.03% 548
2019
Q1
$488K Sell
1,189
-23
-2% -$9.44K 0.06% 306
2018
Q4
$453K Buy
1,212
+255
+27% +$95.3K 0.07% 291
2018
Q3
$387K Buy
957
+60
+7% +$24.3K 0.05% 374
2018
Q2
$309K Buy
897
+28
+3% +$9.65K 0.05% 407
2018
Q1
$299K Sell
869
-719
-45% -$247K 0.06% 392
2017
Q4
$590K Buy
1,588
+12
+0.8% +$4.46K 0.11% 226
2017
Q3
$705K Sell
1,576
-97
-6% -$43.4K 0.14% 162
2017
Q2
$822K Buy
1,673
+253
+18% +$124K 0.19% 127
2017
Q1
$550K Sell
1,420
-43
-3% -$16.7K 0.15% 170
2016
Q4
$537K Buy
1,463
+393
+37% +$144K 0.16% 157
2016
Q3
$430K Buy
1,070
+209
+24% +$84K 0.14% 173
2016
Q2
$301K Buy
861
+39
+5% +$13.6K 0.11% 228
2016
Q1
$296K Sell
822
-38
-4% -$13.7K 0.11% 219
2015
Q4
$467K Sell
860
-49
-5% -$26.6K 0.16% 154
2015
Q3
$423K Sell
909
-33
-4% -$15.4K 0.18% 147
2015
Q2
$433K Buy
942
+134
+17% +$61.6K 0.17% 173
2015
Q1
$365K Sell
808
-19
-2% -$8.58K 0.16% 184
2014
Q4
$339K Buy
827
+109
+15% +$44.7K 0.15% 182
2014
Q3
$259K Buy
+718
New +$259K 0.15% 175